Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection.

Imagen de Paul Lizardi
PDF versionPDF version
TítuloMethylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection.
Publication TypeJournal Article
Year of Publication2014
AutoresBrandsma, JL, Harigopal, M, Kiviat, NB, Sun, Y, Deng, Y, Zelterman, D, Lizardi, PM, Shabanova, VS, Levi, A, Yaping, T, Hu, X, Feng, Q
JournalCancer Prev Res (Phila)
Volume7
Issue5
Pagination526-33
Date Published2014 May
ISSN1940-6215
Abstract

An accurate biomarker for the follow-up of women positive for human papillomavirus type 16 (HPV16) DNA may improve the efficiency of cervical cancer prevention. Previously, we analyzed all 113 HPV16 CpGs in cervical cytology samples and discovered differential methylation at different stages of premalignancy. In the current study, we identified a methylation biomarker consisting of a panel of 12 HPV16 CpG sites in the E5, L2, and L1 open reading frames, and tested whether it fulfilled three necessary conditions of a prospective biomarker. A total of 33 cytology samples from North American and West African women with all grades of cervical intraepithelial neoplasia (CIN) and invasive cervical cancer (ICC) were analyzed by using DNA bisulfite sequencing. The results showed (i) a highly significant trend for increasing HPV16 biomarker methylation with increasing histologic severity (P

DOI10.1158/1940-6207.CAPR-13-0354
Alternate JournalCancer Prev Res (Phila)
PubMed ID24556390